Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Prepaid Assets (2018 - 2025)

10x Genomics' Prepaid Assets history spans 8 years, with the latest figure at $22.2 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 14.42% year-over-year to $22.2 million; the TTM value through Dec 2025 reached $22.2 million, up 14.42%, while the annual FY2025 figure was $22.2 million, 14.42% up from the prior year.
  • Prepaid Assets for Q4 2025 was $22.2 million at 10x Genomics, up from $19.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $25.6 million in Q1 2025 and bottomed at $13.3 million in Q2 2021.
  • The 5-year median for Prepaid Assets is $19.0 million (2022), against an average of $18.4 million.
  • The largest annual shift saw Prepaid Assets soared 103.52% in 2021 before it decreased 10.0% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $13.9 million in 2021, then grew by 19.3% to $16.6 million in 2022, then grew by 13.34% to $18.8 million in 2023, then grew by 3.31% to $19.4 million in 2024, then rose by 14.42% to $22.2 million in 2025.
  • Per Business Quant, the three most recent readings for TXG's Prepaid Assets are $22.2 million (Q4 2025), $19.2 million (Q3 2025), and $20.4 million (Q2 2025).